OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Short-term efficacy and safety of biologics and Janus kinase inhibitors for patients with atopic dermatitis: A systematic review and meta-analysis
Qianyu Chen, Lian Cui, Yifan Hu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22014-e22014
Open Access | Times Cited: 8
Qianyu Chen, Lian Cui, Yifan Hu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e22014-e22014
Open Access | Times Cited: 8
Showing 8 citing articles:
Atopic dermatitis: treatment and innovations in immunotherapy
Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1777-1789
Closed Access | Times Cited: 7
Francesco Ferrara, Andrea Zovi, Maurizio Capuozzo, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 3, pp. 1777-1789
Closed Access | Times Cited: 7
Comparative Real-World Analysis of Baseline Demographic Characteristics and Comorbidities in Atopic Dermatitis Patients Initiating Biologics Versus JAK Inhibitors
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Husein Husein‐ElAhmed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1291-1291
Open Access
Álvaro Prados‐Carmona, F.J. Navarro‐Triviño, Husein Husein‐ElAhmed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1291-1291
Open Access
Comparative efficacy and safety of dupilumab versus newly approved biologics and JAKi in pediatric atopic dermatitis: A systematic review and network meta-analysis
Qiwei Liao, Hong Pan, Yixin Guo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319400-e0319400
Open Access
Qiwei Liao, Hong Pan, Yixin Guo, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0319400-e0319400
Open Access
An updated reappraisal of dupilumab in children and adolescents with moderate–severe atopic dermatitis
Giorgio Ciprandi, Amelia Licari, Maria Angela Tosca, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 6
Closed Access | Times Cited: 2
Giorgio Ciprandi, Amelia Licari, Maria Angela Tosca, et al.
Pediatric Allergy and Immunology (2024) Vol. 35, Iss. 6
Closed Access | Times Cited: 2
Dupilumab in Combination With JAK Inhibitor for Refractory Moderate‐to‐Severe Atopic Dermatitis
Xiaoting Song, Bo Liu, Chengyue Peng, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Xiaoting Song, Bo Liu, Chengyue Peng, et al.
Dermatologic Therapy (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
Navigating the atopic dermatitis toolbox
Archana Samynathan, Jonathan I. Silverberg
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 3, pp. 337-343
Closed Access | Times Cited: 3
Archana Samynathan, Jonathan I. Silverberg
Annals of Allergy Asthma & Immunology (2023) Vol. 132, Iss. 3, pp. 337-343
Closed Access | Times Cited: 3
Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
Yali Ding, Bing He, Daniel Bogush, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Yali Ding, Bing He, Daniel Bogush, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
A comprehensive analysis on the safety of two biologics dupilumab and omalizumab
Yu Xiao, W.H. Yang, M M Wang
Frontiers in Medicine (2024) Vol. 11
Open Access
Yu Xiao, W.H. Yang, M M Wang
Frontiers in Medicine (2024) Vol. 11
Open Access
